Multi-Aspect Device
Our disruptive and innovative technology is addressing a significant and unmet need - that is, to diagnose cancer more accurately and earlier. We are targeting a well-defined market opportunity with accessible channels of distribution and are pursuing a streamlined 510(k) regulatory pathway with go-to-market strategy planned for 2022. Reimbursement codes already exist for our planned products with a related reimbursement strategy already in place, and there is value for all stakeholders – patients, physicians, hospitals, and payers. The company was founded by internationally recognized experts in prostate cancer, and an experienced management team, scientific advisory board, and board of directors with a track record of success.
-
Most popular related searches
Customer reviews
No reviews were found for Multi-Aspect Device. Be the first to review!